218 related articles for article (PubMed ID: 23896123)
21. Humoral responses and immune protection in mice immunized with irradiated T. gondii tachyzoites and challenged with three genetically distinct strains of T. gondii.
Zorgi NE; Costa A; Galisteo AJ; do Nascimento N; de Andrade HF
Immunol Lett; 2011 Aug; 138(2):187-96. PubMed ID: 21545808
[TBL] [Abstract][Full Text] [Related]
22. Protective effect of a DNA vaccine delivered in attenuated Salmonella typhimurium against Toxoplasma gondii infection in mice.
Qu D; Wang S; Cai W; Du A
Vaccine; 2008 Aug; 26(35):4541-8. PubMed ID: 18590785
[TBL] [Abstract][Full Text] [Related]
23. Toxoplasma gondii microneme protein 6 (MIC6) is a potential vaccine candidate against toxoplasmosis in mice.
Peng GH; Yuan ZG; Zhou DH; He XH; Liu MM; Yan C; Yin CC; He Y; Lin RQ; Zhu XQ
Vaccine; 2009 Nov; 27(47):6570-4. PubMed ID: 19720368
[TBL] [Abstract][Full Text] [Related]
24. Immune responses and protection after DNA vaccination against Toxoplasma gondii calcium-dependent protein kinase 2 (TgCDPK2).
Chen K; Wang JL; Huang SY; Yang WB; Zhu WN; Zhu XQ
Parasite; 2017; 24():41. PubMed ID: 29119944
[TBL] [Abstract][Full Text] [Related]
25. Immune response and protective effect against chronic Toxoplasma gondii infection induced by vaccination with a DNA vaccine encoding profilin.
Gao Q; Zhang NZ; Zhang FK; Wang M; Hu LY; Zhu XQ
BMC Infect Dis; 2018 Mar; 18(1):117. PubMed ID: 29514647
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of the adjuvant effect of pidotimod on the immune protection induced by UV-attenuated Toxoplasma gondii in mouse models.
Zhao Y; Huang B; Huang S; Zheng H; Li YQ; Lun ZR; Shen J; Wang Y; Kasper LH; Lu F
Parasitol Res; 2013 Sep; 112(9):3151-60. PubMed ID: 23783399
[TBL] [Abstract][Full Text] [Related]
27. Protective efficacy of recombinant canine adenovirus type-2 expressing TgROP18 (CAV-2-ROP18) against acute and chronic Toxoplasma gondii infection in mice.
Li XZ; Wang XH; Xia LJ; Weng YB; Hernandez JA; Tu LQ; Li LT; Li SJ; Yuan ZG
BMC Infect Dis; 2015 Mar; 15():114. PubMed ID: 25886737
[TBL] [Abstract][Full Text] [Related]
28. Vaccination with Toxoplasma gondii calcium-dependent protein kinase 6 and rhoptry protein 18 encapsulated in poly(lactide-co-glycolide) microspheres induces long-term protective immunity in mice.
Zhang NZ; Xu Y; Wang M; Chen J; Huang SY; Gao Q; Zhu XQ
BMC Infect Dis; 2016 Apr; 16():168. PubMed ID: 27090890
[TBL] [Abstract][Full Text] [Related]
29. Recombinant Toxoplasma gondii phosphoglycerate mutase 2 confers protective immunity against toxoplasmosis in BALB/c mice.
Wang HL; Wen LM; Pei YJ; Wang F; Yin LT; Bai JZ; Guo R; Wang CF; Yin GR
Parasite; 2016; 23():12. PubMed ID: 26984115
[TBL] [Abstract][Full Text] [Related]
30. Toxoplasma gondii rhomboid protein 1 (TgROM1) is a potential vaccine candidate against toxoplasmosis.
Li J; Han Q; Gong P; Yang T; Ren B; Li S; Zhang X
Vet Parasitol; 2012 Mar; 184(2-4):154-60. PubMed ID: 21906881
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of immune responses induced by SAG1 and MIC3 vaccine cocktails against Toxoplasma gondii.
Fang R; Feng H; Hu M; Khan MK; Wang L; Zhou Y; Zhao J
Vet Parasitol; 2012 Jun; 187(1-2):140-6. PubMed ID: 22336771
[TBL] [Abstract][Full Text] [Related]
32. Toxoplasma gondii: serological characterization and immunogenicity of recombinant surface antigen 2 (SAG2) expressed in the yeast Pichia pastoris.
Lau YL; Fong MY
Exp Parasitol; 2008 Jul; 119(3):373-8. PubMed ID: 18457835
[TBL] [Abstract][Full Text] [Related]
33. Immunogenicity and protective efficacy of two recombinant pseudorabies viruses expressing Toxoplasma gondii SAG1 and MIC3 proteins.
Nie H; Fang R; Xiong BQ; Wang LX; Hu M; Zhou YQ; Zhao JL
Vet Parasitol; 2011 Sep; 181(2-4):215-21. PubMed ID: 21632181
[TBL] [Abstract][Full Text] [Related]
34. Immunity in the spleen and blood of mice immunized with irradiated Toxoplasma gondii tachyzoites.
Zorgi NE; Galisteo AJ; Sato MN; do Nascimento N; de Andrade HF
Med Microbiol Immunol; 2016 Aug; 205(4):297-314. PubMed ID: 26732075
[TBL] [Abstract][Full Text] [Related]
35. Toxoplasma gondii: protective immunity against toxoplasmosis with recombinant actin depolymerizing factor protein in BALB/c mice.
Huang X; Li J; Zhang G; Gong P; Yang J; Zhang X
Exp Parasitol; 2012 Mar; 130(3):218-22. PubMed ID: 22248986
[TBL] [Abstract][Full Text] [Related]
36. Enhancement of protective immune responses induced by Toxoplasma gondii dense granule antigen 7 (GRA7) against toxoplasmosis in mice using a prime-boost vaccination strategy.
Min J; Qu D; Li C; Song X; Zhao Q; Li XA; Yang Y; Liu Q; He S; Zhou H
Vaccine; 2012 Aug; 30(38):5631-6. PubMed ID: 22789504
[TBL] [Abstract][Full Text] [Related]
37. Towards vaccine against toxoplasmosis: evaluation of the immunogenic and protective activity of recombinant ROP5 and ROP18 Toxoplasma gondii proteins.
Grzybowski MM; Dziadek B; Gatkowska JM; Dzitko K; Długońska H
Parasitol Res; 2015 Dec; 114(12):4553-63. PubMed ID: 26337271
[TBL] [Abstract][Full Text] [Related]
38. Protective immune response against Toxoplasma gondii elicited by a recombinant DNA vaccine with a novel genetic adjuvant.
Zhou H; Min J; Zhao Q; Gu Q; Cong H; Li Y; He S
Vaccine; 2012 Feb; 30(10):1800-6. PubMed ID: 22240340
[TBL] [Abstract][Full Text] [Related]
39. Toxoplasma gondii: evaluation of an intranasal vaccine using recombinant proteins against brain cyst formation in BALB/c mice.
Igarashi M; Kano F; Tamekuni K; Machado RZ; Navarro IT; Vidotto O; Vidotto MC; Garcia JL
Exp Parasitol; 2008 Mar; 118(3):386-92. PubMed ID: 18154953
[TBL] [Abstract][Full Text] [Related]
40. [Study on construction and immune protective effect of recombinant nucleic acid vaccine of Toxoplasma gondii].
Wei QK
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2012 Apr; 24(2):173-7, 182. PubMed ID: 22799162
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
